Widespread Negative Response Elements Mediate Direct Repression by Agonist- Liganded Glucocorticoid Receptor

Bale, 2000, Mice deficient for corticotrophin-releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress, Nat. genet., 24, 410, 10.1038/74263 Bechtold, 2010, Circadian dysfunction in disease, Trends Pharmacol. Sci., 31, 191, 10.1016/j.tips.2010.01.002 Belvisi, 2001, Therapeutic benefit of a dissociated glucocorticoid and the relevance of In Vitro separation of transrepression from transactivation activity, J. Immunol., 166, 1975, 10.4049/jimmunol.166.3.1975 Bieber, 2008, Atopic dermatitis, N. Engl. J. Med., 358, 1483, 10.1056/NEJMra074081 Boam, 1990, Positive and negative regulation of the human insulin gene by multiple trans-acting factors, J. Biol. Chem., 265, 8285, 10.1016/S0021-9258(19)39070-2 Carey, 2001 Caro, 1982, Glucocorticoid-induced insulin resistance: the importance of postbinding events in the regulation of insulin binding, action, and degradation in freshly isolated and primary cultures of rat hepatocytes, J. Clin. Invest., 69, 866, 10.1172/JCI110526 Chen, 2004, Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotrophin-releasing factor receptor (CRFR) 1-and CRFR2-null mice, and regulation by glucocorticoids, Endocrinology, 145, 2445, 10.1210/en.2003-1570 Chen, 2006, Urocortin 2-deficient mice exhibit gender-specific alterations in circadian hypothalamus-pituitary-adrenal axis and depressive-like behavior, J. Neurosci., 26, 5500, 10.1523/JNEUROSCI.3955-05.2006 Chen, 2000, Interaction of Smad3 with a proximal smad-binding element of the human α2(I) procollagen gene promoter required for transcriptional activation by TGF-β. J, Cell Physiol., 183, 381, 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O Cheng, 2010, TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formation, Cell, 141, 331, 10.1016/j.cell.2010.03.013 Chida, 2007, Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis, Proc. Natl. Acad. Sci. USA, 104, 18205, 10.1073/pnas.0706953104 Chrousos, 2009, Stress and disorders of the stress system, Nat. Rev. Endocrinol., 5, 374, 10.1038/nrendo.2009.106 De Bosscher, 2009, Minireview: latest perspectives on antiinflammatory actions of glucocorticoids, Mol. Endocrinol., 23, 281, 10.1210/me.2008-0283 Delaunay, 1997, Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids, J. Clin. Invest., 100, 2094, 10.1172/JCI119743 Dostert, 2004, Negative glucocorticoid receptor response elements and their role in glucocorticoid action, Curr. Pharm. Des., 10, 2807, 10.2174/1381612043383601 Duez, 2008, Rev-erb alpha gives a time cue to metabolism, FEBS Lett., 582, 19, 10.1016/j.febslet.2007.08.032 Fassler, 1996, Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice, Exp. Cell Res., 222, 111, 10.1006/excr.1996.0014 Frank, 1996, Transforming growth factors β1, β2, and β3 and their receptors are differentially regulated during normal and impaired wound healing, J. Biol. Chem., 271, 10188, 10.1074/jbc.271.17.10188 Geiser, 1998, Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-β1 gene, Bone, 23, 87, 10.1016/S8756-3282(98)00078-7 Gevers, 2002, Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate, J. Bone Miner. Res., 17, 1408, 10.1359/jbmr.2002.17.8.1408 Goodman, 1996, Identification of the human insulin negative regulatory element as a negative glucocorticoid response element, Mol. Cell. Endocrinol., 120, 139, 10.1016/0303-7207(96)03830-0 Gross, K.L., and Cidlowski J.A. Tissue-specific glucocorticoid action: a family affair. (2008). Trends Endocrinol. Metab. 19, 331-339. Karin, 1998, New Twists in Gene Regulation by Glucocorticoid Receptor: Is DNA Binding Dispensable?, Cell, 93, 487, 10.1016/S0092-8674(00)81177-0 Kassel, 2007, Crosstalk between the glucocorticoid receptor and other transcription factors: Molecular aspects, Mol. Cell. Endocrinol., 275, 13, 10.1016/j.mce.2007.07.003 Kleiman, 2007, Glucocorticoid receptor action in beneficial and side effects of steroid therapy: Lessons from conditional knockout mice, Mol. Cell. Endocrinol., 275, 98, 10.1016/j.mce.2007.05.009 Li, 2005, Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin, Proc. Natl. Acad. Sci. USA, 102, 14795, 10.1073/pnas.0507385102 Li, 2006, Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis, Proc. Natl. Acad. Sci. USA, 103, 11736, 10.1073/pnas.0604575103 Li, 2001, Targeted disruption of Col11a2 produces a mild cartilage phenotype in transgenic mice: comparison with the human disorder otospondylomegaepiphyseal dysplasia (OSMED), Dev. Dyn., 222, 141, 10.1002/dvdy.1178 Liu, 2005, Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3′ boundary sequence spanning 46 kilobases, Mol. Cell. Biol., 25, 3220, 10.1128/MCB.25.8.3220-3231.2005 Lonard, 2007, Nuclear receptor coregulators: judges, juries and executioners of cellular regulation, Mol. Cell, 27, 691, 10.1016/j.molcel.2007.08.012 Lu, 2007, Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptorα, Mol. Cell Biol., 27, 7143, 10.1128/MCB.00253-07 Meijsing, 2009, DNA binding site sequence directs glucocorticoid receptor structure and activity, Science, 324, 407, 10.1126/science.1164265 Metherell, 2005, Mutations in MRAP, encoding a nex interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2, Nat. Genet., 37, 166, 10.1038/ng1501 Mocetti, 2001, Bcl-2 and Bax expression in cartilage and bone cells after high-dose corticosterone treatment in rats, Tissue and Cell, 33, 1, 10.1054/tice.2000.0144 Nader, 2010, Interactions of the circadian CLOCK system and the HPA axis, Trends Endocrinol. Metab., 21, 277, 10.1016/j.tem.2009.12.011 Neufeld-Cohen, 2010, A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery, Proc. Natl. Acad. Sci. USA, 107, 19020, 10.1073/pnas.1013761107 Ochala, 2007, Effects of a R133W b-tropomyosin mutation on regulation of muscle contraction in single human muscle fibres, J. Physiol., 581, 1283, 10.1113/jphysiol.2007.129759 Preitner, 2002, The orphan nuclear receptor REV-ERBα controls circadian transcription within the positive limb of the mammalian circadian oscillator, Cell, 110, 251, 10.1016/S0092-8674(02)00825-5 Ramot, 2009, Endocrine controls of keratin expression, Bioessays, 31, 389, 10.1002/bies.200800121 Reddy, 2009, Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation, Genome Res., 19, 2163, 10.1101/gr.097022.109 Rhen, 2005, Antiinflammatory action of glucocorticoids–new mechanisms for old drugs, N. Engl. J. Med., 353, 1711, 10.1056/NEJMra050541 Ricketson, 2007, A conformational switch in the ligand-binding domain regulates the dependence of the glucocorticoid receptor on Hsp90, J. Mol. Biol., 368, 729, 10.1016/j.jmb.2007.02.057 Rogatsky, 1999, Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids, Mol. Cell Biol., 19, 5036, 10.1128/MCB.19.7.5036 Roybal, 2007, Mania-like behavior induced by disruption of CLOCK, Proc. Natl. Acad. Sci. USA, 104, 6406, 10.1073/pnas.0609625104 Sasaki, 2001, Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis, Nephrol. Dial. Transplant., 16, 479, 10.1093/ndt/16.3.479 Schacke, 2002, Mechanisms involved in the side effects of glucocorticoids, Pharmacol. Ther., 96, 23, 10.1016/S0163-7258(02)00297-8 Schakman, 2008, Mechanisms of glucocorticoid-induced myopathy, J. Endocrinol., 197, 1, 10.1677/JOE-07-0606 Schakman, 2008, Role of Akt/GSK-3β/β-Catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats, Endocrinology, 149, 3900, 10.1210/en.2008-0439 Stewart, 1996, Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene, Lancet, 347, 88, 10.1016/S0140-6736(96)90211-1 Szweras, 2002, α2-HS glycoprotein/fetuin, a transforming growth factor-β/Bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling, J. Biol. Chem., 277, 19991, 10.1074/jbc.M112234200 Tan, 2007, Smad4 is required for maintaining normal murine postnatal bone homeostasis, J. Cell Sci., 120, 2162, 10.1242/jcs.03466 Torra, 2000, Circadian and glucocorticoid regulation of Rev-erbα expression in liver, Endocrinology, 141, 3799, 10.1210/endo.141.10.7708 Tuckermann, 1999, The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin, J. Cell Biol., 147, 1365, 10.1083/jcb.147.7.1365 Vaisanen, 2005, Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3, J. Mol. Biol., 350, 65, 10.1016/j.jmb.2005.04.057 Vayssière, 1997, Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo, Mol. Endocrinol., 11, 1245, 10.1210/mend.11.9.9979 Wang, 2004, Chromatin immunoprécipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes, Proc. Natl. Acad. Sci. USA, 101, 15603, 10.1073/pnas.0407008101 Weinstein, 2004, Minireview: GNAS: normal and abnormal functions, Endocrinology, 145, 5459, 10.1210/en.2004-0865 Wrange, 1989, The purified activated glucocorticoid receptor is a homodimer, J. Biol. Chem., 264, 5253, 10.1016/S0021-9258(18)83726-7 Yang, 2003, Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation, Development, 130, 1003, 10.1242/dev.00324 Carey, M., and Smale, S.T. (2001). Transcriptional Regulation in Eukaryotes: Concepts, Strategies, and Techniques (New York: Cold Spring Harbor Laboratory Press). Elbe-Burger, A., Foster, C.A., and Stingl, G. (1997). Immunology Methods Manual, I. Lefkovits, ed. (San Diego: Academic), pp. 1490–1501. Flores-Langarica, A., Meza-Perez, S., Calderon-Amador, J., Estrada-Garcia, T., Macpherson, G., Lebecque, S., Saeland, S., Steinman, R.M., and Flores-Romo, L. (2005). Network of dendritic cells within the muscular layer of the mouse intestine. Proc. Natl. Acad. Sci. USA 102, 19039–19044. Green, S., Issemann, I., and Sheer, E. (1988). A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16, 369. Huang, Da.W., Sherman, B.T., and Lempicki, R.A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57. Li, M., Messaddeq, N., Teletin, M., Pasquali, J.L., Metzger, D., and Chambon, P. (2005). Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc. Natl. Acad. Sci. USA 102, 14795–14800. Liu, Z., and Garrard, W.T. (2005). Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3′ boundary sequence spanning 46 kilobases. Mol. Cell. Biol. 25, 3220–3231. Reddy, T.E., Pauli, F., Sprouse, R.O., Neff, N.F., Newberry, K.M., Garabedian, M.J., and Myers, R.M. (2009). Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 19, 2163–2171. Reichardt, H.M., Kaestner, K.H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., and Schütz, G. (1998). DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93, 531–541. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, Second Edition (New York: Cold Spring Harbor Laboratory Press). Vaisanen, S., Dunlop, T.W., Sinkkonen, L., Frank, C., and Carlberg, C. (2005). Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3. J. Mol. Biol. 350, 65–77. Wang, J.C., Derynck, M.K., Nonaka, D.F., Khodabakhsh, D.B., Haqq, C., and Yamamoto, K.R. (2004). Chromatin immunoprécipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc. Natl. Acad. Sci. USA 101, 15603–15608.